Compare General Motors Company (GM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Motors Company vs GeneDx Holdings Corp — how do they compare? General Motors Company trades at $87.01 (market cap $78.40B), while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). The key difference: General Motors Company is far larger — about 32.1× GeneDx Holdings Corp's market cap, and General Motors Company pays a 0.81% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| GM | WGS | |
|---|---|---|
Market Cap | $78.40B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $90.30 | $167.51 |
52-Week Low | $54.16 | $34.51 |
Enterprise Value | $181.38B | $2.48B |
Dividend Yield | 0.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Motors (GM) trades at $87.19, down 0.88% on the day, with strong technical momentum showing bullish moving average signals. The company has delivered three consecutive earnings beats, with Q2 2026 EPS of $3.57 exceeding the $3.19 estimate. Recent developments include a $4.5 billion parts supply agreement to mitigate future disruptions and a renewed 20-year joint venture with China's SAIC Motor. Analyst consensus remains strongly positive with a $108.82 price target representing 25% upside potential.
GM presents a compelling investment case with attractive valuation metrics including P/S of 0.45 and EV/EBITDA of 10.35, though profitability metrics remain challenged with net margin at 1.05%. Key risks include declining profit margins from 6.33% in 2022 to 1.45% in 2025, high debt levels with debt-to-asset ratio of 46.79%, and ongoing supply chain challenges in the automotive sector.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.
Read more on GM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
